GGrantIndex
← Search

EVALUATION OF A MONOCLONAL ANTIBODY

$843,463N01FY2022AINIH

Dynport Vaccine Company, Llc, Frederick MD

Investigators

Abstract

The Biopharmaceutical Product Development Services program provides services to facilitate preclinical development of materials that are derived from biotechnology processes.

View original record on NIH RePORTER →